An antitumor antibiotic with diverse biological activities
Related Products And Services
Alternative(s)
11421Actinomycin D
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Actinomycin D (solution)

Item No. 46799

Product Insert (PDF)
Technical Information
CAS Number
50-76-0
Synonyms
  • ActD
  • Actinomycin C1
  • Dactinomycin
  • Meractinomycin
  • NCI C04682
  • NSC 3053
  • Oncostatin K
Molecular Formula
C62H86N12O16
Formula Weight
Purity
≥95%
A 1 mM solution in DMSO
DMF: Soluble: ≥10 mg/mlDMSO: Soluble: ≥10 mg/ml
SMILES
CC1=C2C(C(C(N[C@H](C(N[C@@H](C(C)C)C(N3[C@@](C(N(C)CC4=O)=O)([H])CCC3)=O)=O)[C@@H](C)OC([C@H](C(C)C)N4C)=O)=O)=C(N)C1=O)=NC5=C(C(N[C@@H]([C@@H](C)OC([C@H](C(C)C)N(C)C(CN(C([C@]6([H])CCCN6C([C@H](C(C)C)N7)=O)=O)C)=O)=O)C7=O)=O)C=CC(C)=C5O2
InChi Code
InChI=1S/C62H86N12O16/c1-27(2)42-59(84)73-23-17-19-36(73)57(82)69(13)25-38(75)71(15)48(29(5)6)61(86)88-33(11)44(55(80)65-42)67-53(78)35-22-21-31(9)51-46(35)64-47-40(41(63)50(77)32(10)52(47)90-51)54(79)68-45-34(12)89-62(87)49(30(7)8)72(16)39(76)26-70(14)58(83)37-20-18-24-74(37)60(85)43(28(3)4)66-56(45)81/h21-22,27-30,33-34,36-37,42-45,48-49H,17-20,23-26,63H2,1-16H3,(H,65,80)(H,66,81)(H,67,78)(H,68,79)/t33-,34-,36+,37+,42+,43+,44+,45+,48+,49+/m1/s1
InChi Key
RJURFGZVJUQBHK-DCUCITLNSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Actinomycin D is an antitumor antibiotic that has been found in Streptomyces and has diverse biological activities.1,2,3,4,5,6 It binds to replicating DNA at the transcription initiation complex and inhibits RNA polymerase elongation.1,2 It induces apoptosis in PANC-1 pancreatic cancer, MG-63 osteosarcoma, and patient-derived chronic lymphocytic leukemia (CLL) cells.3,4,5 Actinomycin D (0.06 mg/kg, i.p.) reduces tumor load and increases survival in a TCL1 transgenic mouse model of high-risk CLL.5 It is active against B. cereus, S. pneumoniae, and methicillin-susceptible S. aureus (MICs = 3.125, 12.5, and 6.25 µg/ml, respectively), as well as multiple strains of methicillin-resistant S. aureus (MRSA; MICs = 12.5-25 µg/ml).6 Formulations containing actinomycin D have been used in the treatment of cancer.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Paramanathan, T., Vladescu, I., McCauley, M.J., et al. Force spectroscopy reveals the DNA structural dynamics that govern the slow binding of Actinomycin D. Nucleic Acids Res. 40(11), 4925-4932 (2012).

    2. Sobell, H.M. Actinomycin and DNA transcription. Proc. Natl. Acad. Sci. USA 82, 5328-5331 (1985).

    3. Kleeff, J., Kornmann, M., Sawhney, H., et al. Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells. Int. J. Cancer 86(3), 399-407 (2000).

    4. Lu, D.F., Wang, Y.S., Li, C., et al. Actinomycin D inhibits cell proliferations and promotes apoptosis in osteosarcoma cells. Int. J. Clin. Exp. Med. 8(2), 1904-1911 (2015).

    5. Merkel, O., Wacht, N., Sifft, E., et al. Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemia. Leukemia 26(12), 2508-2516 (2012).

    6. Qureshi, K.A., Bholay, A.D., Rai, P.K., et al. Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X2 and actinomycin D produced by novel Streptomyces smyrnaeus UKAQ_23. Sci. Rep. 11(1), 14539 (2021).